{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:57:21Z","timestamp":1761155841717},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.radonc.2014.08.030","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T19:16:18Z","timestamp":1410462978000},"page":"449-450","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radiation-recall dermatitis with the everolimus\/exemestane combination ten years after adjuvant whole-breast radiotherapy"],"prefix":"10.1016","volume":"112","author":[{"given":"Georgios","family":"Ioannidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinelopi","family":"Gkogkou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pandelitsa","family":"Charalampous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Diamandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2014.08.030_b0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1634\/theoncologist.2009-0090","article-title":"Radiation recall with anticancer agents","volume":"15","author":"Burris","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2014.08.030_b0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.prro.2012.03.001","article-title":"Radiation recall reaction with anastrozole treatment in breast cancer","volume":"2","author":"Haydaroglu","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2014.08.030_b0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clbc.2013.12.011","article-title":"Radiation recall reaction with letrozole therapy in breast cancer","volume":"14","author":"Foster","year":"2014","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2014.08.030_b0020","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1535-7163.MCT-05-0400","article-title":"Targeting the Akt\/mammalian target of rapamycin pathway for radiosensitization of breast cancer","volume":"5","author":"Albert","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"Suppl","key":"10.1016\/j.radonc.2014.08.030_b0025","article-title":"NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: a North Central Cancer Treatment Group trial","volume":"30","author":"Ma","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2014.08.030_b0030","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s12325-013-0060-1","article-title":"Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis","volume":"30","author":"Yardley","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.radonc.2014.08.030_b0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/annonc\/mdq741","article-title":"Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect?","volume":"22","author":"Bourgier","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2014.08.030_b0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000353309","article-title":"Radiation-induced esophagitis exacerbated by everolimus","volume":"6","author":"Miura","year":"2013","journal-title":"Case Rep Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014003600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014003600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T18:50:29Z","timestamp":1538247029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814014003600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0167814014003600"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2014.08.030","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-recall dermatitis with the everolimus\/exemestane combination ten years after adjuvant whole-breast radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2014.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}